Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ada Balan"'
Autor:
Ralf Schubert, Thomas Lehrnbecher, Ada Balan, Özer Degistirici, Stanislaw Schmidt, Andreas Schneider, Lars Tramsen, Roland Meisel
Publikováno v:
Oncotarget
Mesenchymal stromal cells (MSCs) are increasingly given as immunotherapy to hematopoietic stem cell transplant (HSCT) recipients with refractory graft-versus-host disease (GvHD). Whereas the immunosuppressive properties of MSCs seem to be beneficial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff11ed9f8d7f5f7e06aae8586fcb618a
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/45182
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/45182
Publikováno v:
Mycoses. 57:8-12
Summary Mucormycoses remain a serious complication in patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). In these patients, mortality rates of mucormycosis reach up to 90%, which is due, at least in part, to the severe an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d298ab561e9bb931f6ee9d56d4e53750
https://doi.org/10.1111/myc.12241
https://doi.org/10.1111/myc.12241
Autor:
Peter Bader, Ada Balan, Stanislaw Schmidt, Lars Tramsen, Andreas Schneider, Roland Meisel, Selim Kuçi, Thomas Lehrnbecher, G Lucchini
Publikováno v:
Leukemia. 28:1941-1948
Mesenchymal stromal cells (MSCs) are multipotent cells, which exhibit broad immunosuppressive activities. Moreover, they may be administered irrespectively of human leukocyte antigen (HLA) compatibility, without inducing life-threatening immunologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c776adaf268c4f9f2440caf0edf431c0
https://doi.org/10.1038/leu.2014.127
https://doi.org/10.1038/leu.2014.127